Daily SPAC Update – December 30, 2024

by | Dec 30, 2024

AMIAU, IMAQ, SUAC Extension Votes. WLAC Starts Separate Trading. GODN, PPYA Extension Votes Set.

Boardroom Alpha SPAC Resources
Full SPAC Listing
SPAC SEC Filings
Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

EXTENSION VOTES
AIMAU – AIMFINITY INVESTMENT CORP I * vote December 30, 2024 -> extend to October 28, 2025
IMAQ – INTERNATIONAL MEDIA ACQUISITION CORP * vote December 30, 2024 -> extend from January 2, 2025 to January 2, 2027
SUAC – SHOULDERUP TECHNOLOGY ACQUISITION CORP * vote December 30, 2024 -> extend to January 24, 2025

SPAC VOTE RESULTS
MITA – COLISEUM ACQUISITION CORP * Extend to Feb 28, 2025 * 856,188 redeemed * trust $11.39
ATMC – ALPHATIME ACQUISITION CORP * Extend to Oct 04, 2025 * 3,403,976 redeemed * trust $11.41
IRAA – IRIS ACQUISITION CORP * Extend to Jun 30, 2025 * 64,453 redeemed * trust $11.44
ALSAF – ALPHA STAR ACQUISITION CORP * Extend to Jun 15, 2025
MITA – COLISEUM ACQUISITION CORP * Deal Approved

OTHER SPAC NEWS
RRAC – RIGEL RESOURCE ACQUISITION CORP * Merger Agreement Amendment

SPAC DEAL & EXTENSION VOTES SET
GODN – Golden Star Acquisition Corp * DEAL VOTE SET: Jan 20, 2025 * trust $11.27
PPYA – Papaya Growth Opportunity Corp I * EXTENSION VOTE SET: Jan 14, 2025 * trust $11.29

SEPARATE WARRANTS/RIGHTS
WLAC on Dec 30

YESTERDAY’S TOP SPAC GAINERS
33.58% ~ $ 7.20 | MARX – Mars Acquisition Corp. (Announced)
2.98% ~ $ 10.72 | HLXB – Helix Acquisition Corp. II (Pre-Deal)
2.72% ~ $ 12.10 | AIMAU – Aimfinity Investment Corp. I (Announced)
2.22% ~ $ 11.53 | BLAC – Bellevue Life Sciences Acquisition Corp. (Announced)
1.32% ~ $ 11.50 | AQU – Aquaron Acquisition Corp. (Announced)

YESTERDAY’S TOP SPAC LOSERS
-9.77% ~ $ 12.00 | WINV – WinVest Acquisition Corp. (Announced)
-7.92% ~ $ 10.81 | GLLI – Globalink Investment Inc. (Announced)
-7.15% ~ $ 11.49 | LATG – LatAmGrowth SPAC (Announced)
-6.30% ~ $ 10.86 | HAIA – Healthcare AI Acquisition Corp. (Announced)
-4.27% ~ $ 10.77 | ESHA – ESH Acquisition Corp. (Pre-Deal)

LATEST SPAC IPO PERFORMANCE
Dec 23 | $ 10.01 | TDAC – Translational Development Acquisition Corp.
Dec 19 | $ 10.05 | RANG – Range Capital Acquisition Corp.
Dec 12 | $ 10.02 | MLAC – Mountain Lake Acquisition Corp.
Dec 12 | $ 9.94 | DRDB – Roman DBDR Acquisition Corp. II
Dec 10 | $ 10.04 | JACS – Jackson Acquisition Co II
Dec 04 | $ 10.02 | SPHA – Shepherd Ave Capital Acquisition Corp
Dec 04 | $ 10.04 | TAVI – Tavia Acquisition Corp.

 

Recent Analysis

Daily SPAC Update – January 16, 2025

LATG DeSPACs to Femco Steel Technology (KBSX). Plum Acquisition III Extension Vote. RRAC and EVGR Extension Votes Set. NOEM Separate Trading on Jan 16. 

Daily SPAC Update – January 15, 2025

$150M Plum Acquisition IV and $50M Ribbon Acquisition SPAC IPOs. Aimfinity (AIMAU) and Quetta (QETA) Extensions Approved. Bowen (BOWN) + Qianzhi BioTech Deal Approved. 

Daily SPAC Update – January 14, 2025

Cohen Circle (CCIR) LOI with Ukranian Firm. BRKH DeSPACs to Blaize (BZAI). PPYA Extension Vote. Aimfinity Extends to Oct 2025. Bowen Acquisition (BOWN) Forward Purchase Agreement. 

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.